Product: Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Reason for recall: Lack of Assurance of Sterility:
Recall initiated: 20251008
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated